NCT04511650 Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019 Status TERMINATED Phase PHASE2
NCT04510207 A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above Status COMPLETED Phase PHASE3
NCT04510012 Characterizing the Immune Response and Neuronal Damage in COVID-19 Status COMPLETED Phase N/A
NCT04509999 Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection Status WITHDRAWN Phase PHASE3
NCT04507256 AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19 Status COMPLETED Phase PHASE1
NCT04504032 A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) Status TERMINATED Phase PHASE2
NCT04503434 Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support Status COMPLETED Phase N/A
NCT04502472 Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma Status TERMINATED Phase PHASE2/PHASE3
NCT04502069 Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen Status WITHDRAWN Phase PHASE1/PHASE2
NCT04501952 Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting Status TERMINATED Phase PHASE3
NCT04501783 Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 Status COMPLETED Phase PHASE3